ClinicalTrials.gg
AvailableNCT07421557Updated Feb 19, 2026

Expanded Access of Occlutech's Atrial Flow Regulator

An expanded access record providing Catheter implantation of Occlutech AFR device, sponsored by Occlutech International AB. Available at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Occlutech International AB · Expanded access

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Expanded access
Access type
Individual patients
Sex
All
01

Study summary

Occlutech AFR use allowed per FDA's Expanded Access program.

Read the detailed description

Occlutech AFR use allowed per FDA's Expanded Access program. Each individual request is sent for FDA approval and the site's IRB approval per regulations.

02

In context

Lead sponsor

Occlutech International AB is the lead sponsor of 17 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-

Exclusion criteria

Exclusion Criteria:

-

04

Access details

Study type
Expanded access
Access type
Individual patients

Available treatment

  • DeviceCatheter implantation of Occlutech AFR device
05

Where to request access

1 of 1 sites recruiting
  • Individual Sites Across the U.S.
    Maple Grove, Minnesota 55369, United States
    Available
06

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
07

Registry details

Key details

Study ID
NCT07421557
Lead sponsor
Occlutech International AB
Responsible party
Sponsor
First posted
Feb 19, 2026
Last update
Feb 19, 2026

Study contacts

Ramona Ruble
Contact
ramona.ruble@occlutech.com
6126449990
Distribution List Distribution List
Contact
physician.requests@occlutech.com
View the source record on ClinicalTrials.gov ↗

Requesting access

Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.

Contact the provider

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion